FDA Approved: SYFOVRE — Original Application (Apellis Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved SYFOVRE (pegcetacoplan) from Apellis Pharmaceuticals for geographic atrophy associated with age-related macular degeneration, marking the first app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• SYFOVRE (pegcetacoplan)

Snippet

ORIG AP for SYFOVRE (PEGCETACOPLAN)